Immunotherapy in NSCLC: exciting emerging strategies

03:50 Biomarkers for immune checkpoint inhibitor therapies in NSCLC: Dr. Tricia Cottrell, Assistant Professor, Queen’s University, Canada
26:35 Using AI to predict immune checkpoint inhibitors efficacy in NSCLC: Dr. David Kwiatkowski, Professor of Medicine, Brigham and Women's Hospital, USA
47:26 NSCLC clinical trials: Immunotherapy combination approaches: Dr. Rajat Thawani, Assistant Professor, University of Chicago, USA